يعرض 81 - 100 نتائج من 65,676 نتيجة بحث عن '(( 50 ((ms decrease) OR (mean decrease)) ) OR ((( 50 ms decrease ) OR ( 5 a decrease ))))', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91

    Characteristics of Gasless Combustion of Core–Shell Al@NiO Microparticles with Boosted Exothermic Performance حسب Shina Maini (19413980)

    منشور في 2024
    "…The PM composite was not able to be ignited at all by a 5 W laser, while the core–shell counterpart ignited at 2.55 ms and was completely combusted within 6.50 ms accompanying a violent impulse.…"
  12. 92

    Characteristics of Gasless Combustion of Core–Shell Al@NiO Microparticles with Boosted Exothermic Performance حسب Shina Maini (19413980)

    منشور في 2024
    "…The PM composite was not able to be ignited at all by a 5 W laser, while the core–shell counterpart ignited at 2.55 ms and was completely combusted within 6.50 ms accompanying a violent impulse.…"
  13. 93

    Description of the myofascial release techniques. حسب Sergio R. Thomaz (20308465)

    منشور في 2024
    "…</b></p><p>Results</p><p>Thirty-eight patients (14 in CRT, 14 in CRT+MRT, and 10 in RUHB), with a mean age of 55 years and 50% male, completed the study. …"
  14. 94

    Study flow diagram. حسب Sergio R. Thomaz (20308465)

    منشور في 2024
    "…</b></p><p>Results</p><p>Thirty-eight patients (14 in CRT, 14 in CRT+MRT, and 10 in RUHB), with a mean age of 55 years and 50% male, completed the study. …"
  15. 95

    Clinical characteristics of the study population. حسب Sergio R. Thomaz (20308465)

    منشور في 2024
    "…</b></p><p>Results</p><p>Thirty-eight patients (14 in CRT, 14 in CRT+MRT, and 10 in RUHB), with a mean age of 55 years and 50% male, completed the study. …"
  16. 96
  17. 97
  18. 98
  19. 99

    Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC–MS/MS-Based Glycoproteomic Approach حسب Jingfu Zhao (3113421)

    منشور في 2020
    "…Here, we applied an LC–MS/MS-based glycoproteomics approach to characterize Fc glycans of an NISTmAb reference material (RM) 8671 (sample B) and a β-1,4-galactosidase-treated NISTmAb (sample A). …"
  20. 100